Advertisement
Advertisement
June 9, 2023
Vein360 Receives FDA Clearance to Reprocess Philips’ Visions PV .035 Digital IVUS Catheter
June 9, 2023—Vein360, a Cincinnati, Ohio–based medical technology company focused on sustainable manufacturing of complex cardiovascular products, announced it has received FDA 510(k) clearance for reprocessing the Visions PV .035 digital intravascular ultrasound catheter (Philips).
The company advised it will notify existing and prospective customers of product availability in the coming weeks.
In the company’s press release, Vein360’s CEO and Cofounder Suzanne Meyer commented, “At Vein360, we are focused on transforming health care through responsible resource utilization. Our commitment to environmentally conscious medical device reprocessing sets the standard for efficiency, affordability, and sustainability in endovascular care.”
Meyer continued, “We understand the pressures that the vascular community is facing with declining reimbursement and increasing costs. At Vein360, we will continue to work tirelessly to reduce procedural cost so that physicians can focus on patient care.”
Advertisement
Advertisement
